Trials / Completed
CompletedNCT02204839
Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM
The Metabolic and Glycaemic Effects of a Combined Basal-Bolus Insulin Reduction And Carbohydrate Feeding Strategy For Evening Exercise in Type 1 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Northumbria University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesise that reducing basal insulin dose (Glargine, Lantus, Sanofi-Aventis, or Detemir, Levemir, Novo Nordisk), whilst employing current carbohydrate feeding and rapid-acting insulin dose recommendations will protect patients with type 1 diabetes from early- and late-onset hypoglycaemia following evening time exercise.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Basal insulin dose |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2014-07-30
- Last updated
- 2015-01-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02204839. Inclusion in this directory is not an endorsement.